Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
about
Pharmacological treatments for fatigue associated with palliative careBisphosphonates and other bone agents for breast cancerDrug therapy for the management of cancer-related fatigueDrug therapy for the management of cancer related fatigueBisphosphonates for breast cancerNational consensus in China on diagnosis and treatment of patients with advanced breast cancerAre there efficacious treatments for treating the fatigue-sleep disturbance-depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL(©))Bisphosphonates in breast cancerPatient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastasesDiagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation OncologyBreast cancer (metastatic).Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.Bisphosphonate-related osteonecrosis of the jaw: historical, ethical, and legal issues associated with prescribing.Quality of life measurement in bone metastases: A literature review.NCCN Task Force Report: Bone Health in Cancer Care.Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.Tumor-Specific Systemic Treatment in Advanced Breast Cancer - How Long does it Make Sense?Bisphosphonates in Breast Cancer Patients with Bone MetastasesRetrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patientsPharmacoeconomic considerations in the treatment of breast cancer.Ibandronate to treat skeletal-related events and bone pain in metastatic bone disease or multiple myeloma: a meta-analysis of randomised clinical trialsTreatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical PracticeIbandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.Bisphosphonates in breast cancer.Ibandronate: efficacy in the treatment of metastatic bone disease.Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.Patient assessment and diagnosis in implant treatment.A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.Optimal management of bone metastases in breast cancer patients.Treatment options for breast cancer and bone metastases.The predictors of poor quality of life in a sample of Saudi women with breast cancer.Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors.Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials.Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.Effects of brucine on vascular endothelial growth factor expression and microvessel density in a nude mouse model of bone metastasis due to breast cancer.
P2860
Q24187756-2E878B5F-1971-4146-9D42-809921FF28FAQ24203656-4C9E4F14-19CF-4FB0-8EEB-1BDCE6F0F3C2Q24234267-7FF4BB23-4A20-41EB-8370-252A5BD3A6F8Q24242050-6E9AD05C-CB8F-4151-BF0A-03E2D2E293F1Q24246519-0C3A753C-AA17-432E-8B5C-8A338DD107EAQ26775621-49AF317F-DADC-4114-A96C-9D1621261064Q26785468-9AFBA351-F46A-460D-AA3B-2F13194751FDQ26859326-BB2622CA-B86E-489D-8A35-F6F83056CDE4Q26997330-90E07E07-98B1-490F-AE86-E8F508B31A4FQ28076646-E90BF5BF-F6B7-4ADD-9EEA-1CCD330B4250Q33448016-2AFC52AF-EBF0-47DC-A800-37ED2CC94449Q33703527-E590A446-3C0C-4DCC-BCC2-FA6837EAD880Q33885770-B1F64454-D132-4EB9-8DD3-21574AF871E0Q34418172-17B47C97-2E8E-4546-B0C1-99B9129DD532Q34617936-F57AA4A5-BE3F-4C1A-8F5E-1AD33ABC85F6Q34818002-747A0D0E-42B3-4F89-9EF8-0A6CAD0CBD76Q34870267-9267C674-7CF4-4BB3-8234-56971A1807DDQ35095548-BC142A2D-9C45-4DC0-B226-E28F2E782B2CQ35123880-9C1C82BB-03E9-4F65-ABBD-7589EAC2EB03Q35205385-D7BD5E57-D1E3-4358-A350-051E62480050Q35650666-6F7EEF6D-C49A-4378-823D-CF544E408CE5Q35667196-572F5AB2-83F1-4C49-89D1-1DD4E749E3F4Q35987738-57F63A9F-E6B3-4D65-90F8-3CECD4A1EC39Q36085307-5DF11F96-93B1-4EFF-ADAB-8487DF4D0ADFQ36429562-E3993C07-5236-463A-BAF6-FBE2A9D77E03Q36459422-73413F24-ABF2-438E-B3E5-1488459967BCQ36681335-6E3293D8-CADF-4594-A301-CDC7900CEFD9Q36823566-68B771F4-AB17-4218-B6EA-EF45A5BF6345Q37171114-4A5C2200-5D13-4D3F-8E9E-94052A66EC54Q37241474-DC05756F-034D-4B70-A35F-0831E9DF81CDQ37355487-510E25B1-11BE-4D10-9602-78191DD2571BQ37401841-873832D3-2102-4E72-8313-6087EC29FA35Q37641305-1D20A23E-DDD6-458B-B0E7-49533204E615Q37708869-9D14D8C6-C6BF-42C0-9474-B2937C8203BCQ37827010-856CE86F-776E-47A9-BE13-0ABFF45B3016Q38040123-0A0B98DF-D4E6-4352-9722-C091EE5CBD11Q38162877-9876F70A-2122-4813-A191-DB4914979438Q38297692-1AF2D567-7D7C-4F4B-9297-F3E8E2BFC0BEQ38785899-F5C2C4B2-1134-4288-823D-D72118656030Q39303953-2C1468FD-7C8E-4A4E-8F90-C122AD887E2C
P2860
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Improved quality of life after ...... disease due to breast cancer.
@en
Improved quality of life after ...... disease due to breast cancer.
@nl
type
label
Improved quality of life after ...... disease due to breast cancer.
@en
Improved quality of life after ...... disease due to breast cancer.
@nl
prefLabel
Improved quality of life after ...... disease due to breast cancer.
@en
Improved quality of life after ...... disease due to breast cancer.
@nl
P2093
P1476
Improved quality of life after ...... disease due to breast cancer.
@en
P2093
B Bergström
E D Kreuser
M R Lichinitser
MF 4265 Study Group
V A Gorbunova
P304
P356
10.1016/J.EJCA.2004.03.025
P577
2004-07-01T00:00:00Z